Skip NavigationSkip to Content

Attenuation of immune-mediated bone marrow damage in conventionally housed mice

  1. Author:
    Li, Jun
    Dubois, Wendy
    Thovarai,Vishal
    Wu, Zhijie
    Feng, Xingmin
    Peat, Tyler
    Zhang, Shuling
    Sen,Shurjo
    Trinchieri,Giorgio
    Chen, Jichun
    Mock, Beverly A [ORCID]
    Young, Neal S
  2. Author Address

    Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Department of Hematology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China., Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Basic Science Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland., Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.,
    1. Year: 2020
    2. Date: Feb
    3. Epub Date: 2020 01 02
  1. Journal: Molecular carcinogenesis
    1. 59
    2. 2
    3. Pages: 237-245
  2. Type of Article: Article
  3. ISSN: 0899-1987
  1. Abstract:

    In humans, bone marrow (BM) failure syndromes, both constitutional and acquired, predispose to myeloid malignancies. We have modeled acquired immune aplastic anemia, the paradigmatic disease of these syndromes, in the mouse by infusing lymph node cells from specific pathogen-free (SPF) CD45.1 congenic C57BL/6 (B6) donors into hybrid CByB6F1 recipients housed either in conventional (CVB) or SPF facilities. The severity of BM damage was reduced in CVB recipients; they also had reduced levels of CD44+ CD62L- effector memory T cells, reduced numbers of donor-type CD44+ T cells, and reduced expansion of donor-type CD8 T cells carrying T-cell receptor ß-variable regions 07, 11, and 17. Analyses of fecal samples through 16S ribosomal RNA amplicon sequencing revealed greater gut microbial alpha diversity in CVB mice relative to that of SPF mice. Thus, the presence of a broader spectrum of gut microorganisms in CVB-housed CByB6F1 could have primed recipient animal's immune system leading to suppression of allogeneic donor T-cell activation and expansion and attenuation of host BM destruction. These results suggest the potential benefit of diverse gut microbiota in patients receiving BM transplants. © 2019 Wiley Periodicals, Inc.

    See More

External Sources

  1. DOI: 10.1002/mc.23151
  2. PMID: 31898340
  3. WOS: 000505194800001

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel